Cargando…
α-Galactosylceramide protects swine against influenza infection when administered as a vaccine adjuvant
Natural killer T (NKT) -cells activated with the glycolipid ligand α-galactosylceramide (α-GalCer) stimulate a wide array of immune responses with many promising immunotherapeutic applications, including the enhancement of vaccines against infectious diseases and cancer. In the current study, we eva...
Autores principales: | Artiaga, Bianca L., Yang, Guan, Hackmann, Timothy J., Liu, Qinfang, Richt, Jürgen A., Salek-Ardakani, Shahram, Castleman, William L., Lednicky, John A., Driver, John P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4804283/ https://www.ncbi.nlm.nih.gov/pubmed/27004737 http://dx.doi.org/10.1038/srep23593 |
Ejemplares similares
-
Comparison of oseltamivir and α-galactosylceramide for reducing disease and transmission in pigs infected with 2009 H1N1 pandemic influenza virus
por: Madrid, Darling Melany de C., et al.
Publicado: (2022) -
Evaluating α-galactosylceramide as an adjuvant for live attenuated influenza vaccines in pigs
por: Artiaga, Bianca L., et al.
Publicado: (2022) -
Rapid control of pandemic H1N1 influenza by targeting NKT-cells
por: Artiaga, Bianca L., et al.
Publicado: (2016) -
Modulation of Immune Responses to Influenza A Virus Vaccines by Natural Killer T Cells
por: Driver, John P., et al.
Publicado: (2020) -
Combination of the toll like receptor agonist and α-Galactosylceramide as an efficient adjuvant for cancer vaccine
por: Gableh, Fateme, et al.
Publicado: (2016)